VAYEMAhttps://vayema.clinic/assessment-self-tests/polysubstance-use/

Assessment & self-checks

Polysubstance use: Interactive Self-Assessment

Clinically reviewed Dr. Sarah Boss, MD

Updated

Original VAYEMA symptom and impact self-check – not a validated scale

Use of multiple substances

Answer the symptom statements below to see which experiences and areas of daily life you report as most affected. These are original VAYEMA questions, not a validated diagnostic scale. No clinical severity or probability score is calculated.

Answers are processed only in this page by this assessment. They are not submitted, monitored or automatically saved. No name, email or account is required. Use a private device and clear your answers when finished.

For adults aged 18 and over. This self-check cannot diagnose or rule out a condition. Concerns about a child require an age-appropriate professional assessment.

Thinking about the past four weeks, how well does each statement describe your experience?

1. I combine substances to change or manage their effects.
2. It is difficult to keep to intended limits when more than one substance is involved.
3. Combined use or its after-effects disrupt daily responsibilities.
4. I use again despite troubling physical or mental effects.

Additional context – not included in any questionnaire score

Have these experiences persisted or repeatedly returned beyond the period covered by this check?
Have these experiences changed noticeably from your usual pattern?
How difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?

These are original VAYEMA questions, not a diagnostic instrument or a validated severity scale. They summarize the experiences you select and do not predict a diagnosis or future harm. Background condition information; this source does not endorse this self-check.

What a polysubstance assessment is for

The assessment aims to understand current risks and the wider pattern so that care can be planned coherently. Exposure to more than one substance does not automatically establish several addictions, and taking several prescribed medicines is not the same as misuse. The clinician needs to distinguish appropriate treatment, physical dependence, harmful interactions and substance-use-disorder symptoms rather than make assumptions from the number of products listed.

A person may come with one clear concern or simply a sense that a complicated pattern is becoming harder to manage. Either is a valid starting point. The CDC introduction to polysubstance use explains intentional and unintentional combinations. Our understanding guide adds context, but you do not need to read it or select a diagnosis before speaking with a professional.

Make one accurate list, without guessing at details

Include prescribed medicines, pharmacy products, supplements, alcohol and non-prescribed substances. The clinician may need names, formulations, intended uses and the actual pattern of taking them. Where a product’s contents or strength are unknown, say so. A photograph of legitimate medication packaging or an existing list may help at the appointment, but sensitive information should be shared through an appropriate clinical channel.

The worksheet does not need a detailed medical record or information about other people. You can begin with broad notes and discuss specifics privately. Avoid leaving out a medicine because it seems ordinary or a substance because its use is infrequent. The purpose is not a judgment about which products are acceptable; it is to identify relevant interactions and plan safely. Missing information should be acknowledged, not filled in with invented precision.

Describe the sequence as well as the substances

A typical day or week can reveal links that are less clear in a simple inventory. For example, a product used to sleep may follow one used to remain alert. Alcohol may affect how prescribed medication is taken. A clinician can explore these relationships without assuming they explain everything. The timing of symptoms, medication changes and periods of reduced use may all be informative.

Do not deliberately combine, omit or change products to test a theory before the appointment. The review should describe what is happening, not create an experiment. NICE guidance on dependence-forming medicines supports planned review rather than abrupt unsupervised withdrawal. A few representative observations are often more useful than a minute-by-minute record that becomes burdensome or delays seeking care.

Tell the clinician about withdrawal and overdose history

Previous seizures, severe confusion, hallucinations, loss of consciousness, breathing problems or hospital treatment can change the assessment. So can symptoms after missed doses or attempts to stop. A person may minimize an episode because it resolved, or assume that surviving it means the next one will be manageable. Neither conclusion is a reliable basis for choosing a safe setting.

Describe the event and what was known at the time, including any uncertainties. Earlier records can be useful when available, but urgent care should not wait for them. The FDA benzodiazepine warning illustrates why prescribed treatment and abrupt changes can matter alongside non-medical substances. Tell the receiving professional about current symptoms directly rather than assume an unmonitored worksheet communicates urgency.

Screening is one source of information, not a verdict

Professionals may use structured screening instruments to identify substance-related concerns and guide discussion. The WHO ASSIST is designed for healthcare settings and has specific administration and interpretation requirements. A score from an appropriate instrument can support a conversation, but it does not replace assessment of the person’s current condition or decide that home withdrawal is safe.

This page does not reproduce ASSIST or create an alternative diagnostic score. The original prompts organize information without classifying severity. That distinction is important when the problem involves several substances with different risks. A single total could obscure a medically important feature even when other answers appear reassuring. You can seek support without any questionnaire, and a clinician should listen to concerns that are not captured well by a form.

What examination and laboratory tests can clarify

Depending on the presentation, a clinician may assess physical health, alertness, breathing, cardiovascular symptoms and other concerns. Investigations may help answer specific medical questions. Toxicology testing can identify selected exposures but has limitations; it does not establish every product taken, its clinical significance or the whole pattern of dependence and impairment. Results need interpretation alongside the history and examination.

Ask why a test is being proposed and how it would affect the recommendation when the situation allows discussion. A broad testing package is not automatically better, and a normal result should not be taken as proof that every risk has been excluded. Similarly, a positive result is not a complete addiction diagnosis. The useful output is a reasoned clinical understanding and plan, not simply a collection of laboratory findings.

Discuss mental health and practical life together

The assessment may explore sleep, anxiety, depression, pain, trauma-related symptoms or difficulties with daily responsibilities. Substance effects and other conditions can overlap. The clinician may need to revisit conclusions as the situation changes rather than assign every symptom permanently to one cause. Explain what predates use, what changed recently and what remains uncertain without forcing the history into a neat story.

You can also discuss work, housing, family responsibilities and barriers to attending care. These do not override medical safety, but they affect how treatment can be used. A realistic recommendation should identify what support is available and where referral is needed. NIDA’s recovery overview describes the importance of addressing needs beyond substance use alone. Practical coordination should remain connected to clinical decisions.

Ask who will coordinate the recommendations

When a GP, psychiatrist, pain clinician and addiction specialist are involved, responsibilities can become unclear. Ask who leads the current plan, who prescribes and how updates reach other professionals. A written list of medicines and agreed changes can help, but someone must be responsible for keeping it accurate. You should not be expected to resolve contradictory prescriptions or decide the order of reductions yourself.

With appropriate permission, care coordination may help organize appointments and records. Family support can address relatives’ own concerns while respecting your privacy. These roles should be distinguished from treatment and emergency monitoring. Ask which messages go to administrative staff, which reach a clinician and what to do when a concern cannot wait for the stated response time.

The assessment may recommend individual outpatient care, more coordinated support, specialist withdrawal management or hospital treatment. The appropriate level follows current symptoms, dependence, physical health and available support, not simply how many substances are named. A preference for minimal disruption should be heard, but a website cannot establish that remaining at home is safe during a serious presentation.

The treatment guide explains possible components. Ask why they are proposed, what alternatives exist, what they cost and when the first review happens. The plan should identify what to do if symptoms change before then. A large program is not inherently more appropriate, and a brief appointment is not sufficient merely because it fits a calendar. Clinical reasoning should be understandable.

Keep notes private and urgent help separate

The worksheet retains only what you type for use in the current page and does not send it to the clinic. It does not notify staff, create a patient record or calculate interaction risks. A deliberate download is a file under your control and should be stored privately. You can clear the notes or stop using them whenever preparation becomes unhelpful.

For planned care, VAYEMA’s assessment pathway can clarify appropriate expertise and practical arrangements. If an overdose may be occurring, call emergency services. Where opioid exposure is possible, use available naloxone according to its instructions while help is called, and follow emergency guidance. The CDC naloxone resource explains its role. No online worksheet or routine inquiry should delay an emergency response.

Frequently asked questions about polysubstance assessment

Will the worksheet give me an addiction score?

No. It is an original unscored preparation aid, not a validated diagnostic instrument or a copy of ASSIST. It repeats your observations without interpreting them. A clinician needs to assess each substance, current symptoms and the wider pattern. No result is required before seeking care, and there is no pass or fail.

Should I list medicines that I take exactly as prescribed?

Yes, when relevant to the clinical review. Appropriate prescribing is not automatically misuse, but interactions and physical dependence may still matter. Explain the intended use and actual pattern without assuming that a prescribed medicine is either harmless or evidence of addiction. Do not stop it independently because you are preparing for assessment.

What if I do not know what was in a non-medical product?

State the uncertainty and describe any known name, timing or symptoms. Do not invent an ingredient or amount to complete a field. Clinicians can assess the current situation and decide what additional information is useful. Serious symptoms require prompt medical care even when the exact exposure cannot be established.

Can I use a test result to decide which substance to stop first?

No. That decision requires medical review of dependence, interactions, current symptoms and treatment needs. Some abrupt changes can be dangerous. A screening score or drug test does not establish a withdrawal sequence. Ask the responsible clinician for an individual plan rather than combine advice from different online sources.

Can a family member join the appointment?

That can be discussed when arranging care. Their observations may be useful, but their account should be distinguished from yours and privacy arrangements explained. You may want part of the consultation alone. Family involvement is not automatic access to all records, and payment for treatment does not determine confidentiality.

Does entering a serious symptom send an alert?

No. Nothing in the worksheet is transmitted or monitored. Use medical or emergency services directly for an urgent concern. A routine VAYEMA inquiry is also not continuous crisis cover. The notes are optional preparation for an appropriate conversation and should never postpone necessary treatment or observation.

Resources and references

[1] CDC: polysubstance use facts

[2] NICE NG215: medicine review and withdrawal planning

[3] FDA: benzodiazepine safety and dependence warnings

[4] WHO: ASSIST manual for healthcare settings

[5] NIDA: treatment and recovery

[6] CDC: lifesaving naloxone

Start with a private assessment.

Private and discreet from the first conversation. Tell us how and when you prefer to be contacted, using contact details and practical preferences only.

VAYEMA

What would you like to explore?

Enter at least two characters to search.

VAYEMA

Private mental health care

Let us help you find the next step.

You do not need to choose a clinician or treatment program in advance.

Private and discreet from the first conversation. Tell us how and when you prefer to be contacted, using contact details and practical preferences only.

This form sends your information by email to [email protected]. Please do not include symptoms, medical histories, medication details or clinical documents.

Preferred session format

Select any that suit you.

Your preferred format, practitioner availability and any fees are discussed before an appointment is agreed. For urgent help, contact local emergency services rather than waiting for this form.

Prefer email? Contact [email protected].

Read our privacy information before sharing personal information.

VAYEMAYOUR NEXT STEP
Automated service guide Not clinical care English

You do not have to figure it out alone.

Explore what support could look like, at your own pace. You do not need a diagnosis or the right words to begin.